Affect Therapeutics is a leading provider of substance use disorder treatment, offering a comprehensive, digitally-delivered program that combines behavioral engineering, gamification, and contingency management to stimulate the brain's reward center and promote recovery. The company's CARF-accredited program, supported by NIDA and NIH, has demonstrated outcomes more than double those of traditional rehab models, making it a highly effective solution for those battling addiction. With a focus on accessibility and privacy, Affect Therapeutics' program is available via a smartphone app, providing individuals with direct access to their care team, progress tracking, and therapy sessions, while also assisting with life improvements outside of treatment, making it a holistic and supportive workplace for those dedicated to combating the nation's addiction crisis.